1. Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy
    Francesco Pasqualetti et al, 2017, Mol Neurobiol CrossRef
  2. Sphingosine Kinase-1 Involves the Inhibitory Action of HIF-1α by Chlorogenic Acid in Hypoxic DU145 Cells
    Myoung-Sun Lee et al, 2017, IJMS CrossRef
  3. null
    Fatemeh Karami et al, 2017 CrossRef
  4. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
    Romana-Rea Begicevic et al, 2017, Int J Mol Sci CrossRef
  5. Multiple Administrations of 64 Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts
    Yukie Yoshii et al, 2018, Translational Oncology CrossRef
  6. Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients
    Shayna Stein et al, 2018, PLoS Comput Biol CrossRef
  7. Glioma infiltration and extracellular matrix: key players and modulators
    Valéria Pereira Ferrer et al, 2018, Glia CrossRef
  8. Modulation of biomimetic properties of cerium oxide nanoparticles by hypoxic tumor microenvironments: steering towards tumor specificity
    Preethi Sridharan et al, 2018, New J. Chem. CrossRef
  9. VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
    Maurizio Martini et al, 2018, BMC Cancer CrossRef
  10. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma
    Hui Shan Ong et al, 2018, J Oral Pathol Med CrossRef
  11. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumour development
    Marina Kazantseva et al, 2018, J. Pathol. CrossRef
  12. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme
    Gulten Tuncel et al, 2018, Med Oncol CrossRef
  13. Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
    Katherine L. Eales et al, 2018, Sci Rep CrossRef
  14. Non-Coding RNAs in Glioma.
    Ryte Rynkeviciene et al, 2018, Cancers (Basel) CrossRef
  15. null
    Yujiao Gong et al, 2019 CrossRef
  16. Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12
    Frank Giordano et al, 2019, Cancers CrossRef
  17. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
    Giovanni Gravina et al, 2019, Cancers CrossRef
  18. null
    Niha G. Beig et al, 2019 CrossRef
  19. Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
    Alessia Lo Dico et al, 2019, Front. Oncol. CrossRef
  20. Preclinical Pharmacokinetic and Safety Studies of Copper-Diacetyl-Bis(N4-Methylthiosemicarbazone) (Cu-ATSM): Translational Studies for Internal Radiotherapy
    Hiroki Matsumoto et al, 2019, Translational Oncology CrossRef
  21. The flashlights on a distinct role of protein kinase C δ: Phosphorylation of regulatory and catalytic domain upon oxidative stress in glioma cells
    Matus Misuth et al, 2017, Cellular Signalling CrossRef
  22. Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling
    Daniel Uribe et al, 2017, Molecular Aspects of Medicine CrossRef
  23. Synergism between PKCδ regulators hypericin and rottlerin enhances apoptosis in U87 MG glioma cells after light stimulation
    Matus Misuth et al, 2017, Photodiagnosis and Photodynamic Therapy CrossRef
  24. Angiogenesis inhibitors in tackling recurrent glioblastoma.
    Thomas Hundsberger et al, 2017, Expert Rev Anticancer Ther CrossRef
  25. Bioactive lipids in cancer stem cells
    Romana-Rea Begicevic et al, 2019, WJSC CrossRef
  26. Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies
    Vashendriya V.V. Hira et al, 2019, J Histochem Cytochem. CrossRef
  27. SENP1/HIF-1α feedback loop modulates hypoxia-induced cell proliferation, invasion, and EMT in human osteosarcoma cells
    Xiaowei Wang et al, 2017, J Cell Biochem CrossRef
  28. The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
    Sergiu Susman et al, 2019, Diagn Pathol CrossRef
  29. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
    Franciele Aline Bruinsmann et al, 2019, Molecules CrossRef
  30. Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers
    Natale Quartuccio et al, 2020, Clin Transl Imaging CrossRef
  31. M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition
    Ilaria Cristofaro et al, 2020, IJMS CrossRef
  32. Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
    Marco Papale et al, 2020, Int J Mol Sci CrossRef
  33. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme
    Marek Mazurek et al, 2020, IJMS CrossRef
  34. Penta-fluorophenol: a Smiles rearrangement-inspired cysteine-selective fluorescent probe for imaging of human glioblastoma
    Jong Min An et al, 2020, Chem. Sci. CrossRef
  35. Matrix stiffness modulates patient-derived glioblastoma cell fates in 3D hydrogels
    Christine Wang et al, 2020, Tissue Engineering Part A CrossRef
  36. Advances in drug delivery technology for the treatment of glioblastoma multiforme
    Gi Doo Cha et al, 2020, Journal of Controlled Release CrossRef
  37. A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels
    Christine Wang et al, 2020, Acta Biomaterialia CrossRef
  38. The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
    Filippo Torrisi et al, 2020, Cancers CrossRef
  39. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles in Epidermal Growth Factor Receptor Overexpressing Glioblastoma Cells
    Asmita Banstola et al, 2020, Mol. Pharmaceutics CrossRef
  40. A Review of Newly Diagnosed Glioblastoma
    Bryan Oronsky et al, 2021, Front. Oncol. CrossRef
  41. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas
    Shalini Sundramurthi Chelliah et al, 2021, Molecules CrossRef
  42. The Multifaceted Role of CMA in Glioma: Enemy or Ally?
    Alessia Lo Dico et al, 2021, IJMS CrossRef
  43. The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response
    Rebekah L. I. Crake et al, 2021, Front. Oncol. CrossRef
  44. Hypoxia Transcriptomic Modifications Induced by Proton Irradiation in U87 Glioblastoma Multiforme Cell Line
    Valentina Bravatà et al, 2021, JPM CrossRef
  45. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
    Wei Wu et al, 2021, Pharmacol Res CrossRef
  46. An analysis of lesions associated with developmental venous anomalies
    O Taydas et al, 2021, annals CrossRef
  47. Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM
    Chika Igarashi et al, 2022, Nuclear Medicine and Biology CrossRef
  48. Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity
    Daniel Uribe et al, 2022, Biology CrossRef
  49. Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival
    Eleanor R. Burgess et al, 2022, Front. Oncol. CrossRef
  50. Evaluation of miRNA Expression in Glioblastoma Stem-Like Cells: A Comparison between Normoxia and Hypoxia Microenvironment
    Lucy Macharia et al, 2022, Onco CrossRef
  51. Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth
    Shreoshi Sengupta et al, 2022 CrossRef
  52. Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study
    Michele Bailo et al, 2022, Front. Neurosci. CrossRef
  53. Medical Device Advances in the Treatment of Glioblastoma
    Cher Ying Foo et al, 2022, Cancers CrossRef
  54. Evolving role of regorafenib for the treatment of advanced cancers.
    Axel Grothey et al, 2020, Cancer Treat Rev CrossRef
  55. Measurement of Cerebral Oxygen Extraction Fraction Using Quantitative BOLD Approach: A Review
    Hongwei Li et al, 2022, Phenomics CrossRef
  56. Profiling and Bioinformatics Analyses of Differential Circular RNA Expression in Glioblastoma Multiforme Cells Under Hypoxia
    Zheng Chen et al, 2022, J Mol Neurosci CrossRef
  57. New therapeutic strategies based on molecularly targeted therapy in glioblastoma – a case report and review of the literature
    Katarzyna Szklener et al, 2022 CrossRef
  58. A Rare Triploid Involving the Coexistence of Glioblastoma Multiforme, Arteriovenous Malformation and Intracranial Aneurysm: Illustrative Case and Literature Review
    Chi-Ruei Li et al, 2023, Medicina CrossRef
  59. Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme
    Smita Kumari et al, 2023, ACS Omega CrossRef
  60. Recent Progress in Fluorescent Probes for Real-Time Monitoring of Glioblastoma
    Amita Mondal et al, 2023, ACS Appl. Bio Mater. CrossRef
  61. Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations
    Żaneta Kałuzińska-Kołat et al, 2023, World J Stem Cells CrossRef
  62. Advances in Glioblastoma Therapy: An Update on Current Approaches
    Ramcharan Singh Angom et al, 2023, Brain Sciences CrossRef
  63. Trace Metal Impurities Effects on the Formation of [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM)
    Mitsuhiro Shinada et al, 2023, Pharmaceuticals CrossRef
  64. The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression.
    Filippo Torrisi et al, 2022, Biomedicines CrossRef
  65. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
    Ashley Irin Cortes Ballen et al, 2024, Cells CrossRef